Medplus Health Services Limited — Important, 16-07-2025: General Updates

MedPlus's subsidiary, Optival Health Solutions, received a 7-day drug license suspension for one of its Maharashtra stores. This operational disruption, resulting from a compliance issue, is projected to cause a potential revenue loss of approximately ₹0.007 Cr. While a minor financial impact, investors should be aware of this regulatory action on the company's retail operations. Monitoring future compliance and the broader operational stability remains key for stakeholders.